中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2010年
1期
33-37
,共5页
吴吉芹%徐斌%区雪婷%朱利平%翁心华
吳吉芹%徐斌%區雪婷%硃利平%翁心華
오길근%서빈%구설정%주리평%옹심화
脑膜炎%隐球菌性%死亡率%预后
腦膜炎%隱毬菌性%死亡率%預後
뇌막염%은구균성%사망솔%예후
Meningitis,cryptococcal%Mortality%Prognosis
目的 探讨影响非艾滋病(AIDS)相关隐球菌脑膜炎(隐脑)的预后因素.方法 收集复旦大学附属华山医院感染科11年(1997至2007年)间收治的154例非MDS相关隐脑病例,并随访1年,分析影响其病死率的危险因素.结果 随访1年中,全因病死率为28.7%(41/143,11例失访),归因病死率为19.6%(28/143).单因素分析结果 显示,与全因病死率增加显著相关的因素包括年龄≥60岁、血液恶性肿瘤、实体恶性肿瘤、发病至确诊时间>4个月、病程中出现意识障碍(昏迷、癫痫发作、脑疝),以及行脑脊液脑室外引流或分流术等.与全因病死率减少显著相关的因素包括初始治疗方案中含有两性霉素B者、初始治疗方案中含有氟胞嘧啶者,以及两性霉素B鞘内注射者.Cox多元回归分析结果 显示,与全因病死独立相关的因素包括年龄≥60岁、发病至确诊时间>4个月、昏迷、脑疝,以及初始治疗方案不含两性霉素B者;与归因病死独立相关的因素包括发病至确诊时间>4个月、脑疝以及初始治疗方案不含两性霉索B者.结论 非AIDS相关隐脑患者中年龄≥60岁、意识障碍、发病至确诊时间>4个月者预后不佳,应用两性霉素B的初始治疗对预后改善起着关键性作用.
目的 探討影響非艾滋病(AIDS)相關隱毬菌腦膜炎(隱腦)的預後因素.方法 收集複旦大學附屬華山醫院感染科11年(1997至2007年)間收治的154例非MDS相關隱腦病例,併隨訪1年,分析影響其病死率的危險因素.結果 隨訪1年中,全因病死率為28.7%(41/143,11例失訪),歸因病死率為19.6%(28/143).單因素分析結果 顯示,與全因病死率增加顯著相關的因素包括年齡≥60歲、血液噁性腫瘤、實體噁性腫瘤、髮病至確診時間>4箇月、病程中齣現意識障礙(昏迷、癲癇髮作、腦疝),以及行腦脊液腦室外引流或分流術等.與全因病死率減少顯著相關的因素包括初始治療方案中含有兩性黴素B者、初始治療方案中含有氟胞嘧啶者,以及兩性黴素B鞘內註射者.Cox多元迴歸分析結果 顯示,與全因病死獨立相關的因素包括年齡≥60歲、髮病至確診時間>4箇月、昏迷、腦疝,以及初始治療方案不含兩性黴素B者;與歸因病死獨立相關的因素包括髮病至確診時間>4箇月、腦疝以及初始治療方案不含兩性黴索B者.結論 非AIDS相關隱腦患者中年齡≥60歲、意識障礙、髮病至確診時間>4箇月者預後不佳,應用兩性黴素B的初始治療對預後改善起著關鍵性作用.
목적 탐토영향비애자병(AIDS)상관은구균뇌막염(은뇌)적예후인소.방법 수집복단대학부속화산의원감염과11년(1997지2007년)간수치적154례비MDS상관은뇌병례,병수방1년,분석영향기병사솔적위험인소.결과 수방1년중,전인병사솔위28.7%(41/143,11례실방),귀인병사솔위19.6%(28/143).단인소분석결과 현시,여전인병사솔증가현저상관적인소포괄년령≥60세、혈액악성종류、실체악성종류、발병지학진시간>4개월、병정중출현의식장애(혼미、전간발작、뇌산),이급행뇌척액뇌실외인류혹분류술등.여전인병사솔감소현저상관적인소포괄초시치료방안중함유량성매소B자、초시치료방안중함유불포밀정자,이급량성매소B초내주사자.Cox다원회귀분석결과 현시,여전인병사독립상관적인소포괄년령≥60세、발병지학진시간>4개월、혼미、뇌산,이급초시치료방안불함량성매소B자;여귀인병사독립상관적인소포괄발병지학진시간>4개월、뇌산이급초시치료방안불함량성매색B자.결론 비AIDS상관은뇌환자중년령≥60세、의식장애、발병지학진시간>4개월자예후불가,응용량성매소B적초시치료대예후개선기착관건성작용.
Objective To investigate factors associated with mortality in non-AIDS patients with cryptococcal meningitis. Methods We retrospectively reviewed 154 cases of non-HIV cryptococcal meningitis in a tertiary care hospital in China, from 1997 through 2007. Results The 1-year attributable mortality was 19.6% (28/143), and overall mortality was 28.7% (41/143). Advanced age (≥60 years) , delay in diagnosis ( >4 months) , hematologic malignancy, solid malignancy, altered mental status (coma, seizure, herniation) , and CSF drainage or shunting were factors associated with increased death; factors associated with increased survival were amphotericin B based initial therapy and flucytosine containing therapy. In multivariate analysis, age ≥60 years, the time from symptom onset to diagnosis > 4 months, coma, cerebral herniation, and non-amphotericin B based initial therapy were independently associated with increased overall mortality; factors independently associated with cause-specific mortality were time from symptom onset to diagnosis > 4 months, cerebral herniation and non-amphotericin B based initial therapy. Conclusion A variety of factors were associated with mortality in non-AIDS cryptococcal meningitis. Amphotericin B based initial treatment was independently correlated to improved 1-year survival.